Evidence map›Paper›PMID 21147848›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2011

Luteinizing hormone receptor mRNA down-regulation is mediated through ERK-dependent induction of RNA binding protein.

Bindu Menon, Megan Franzo-Romain, Shadi Damanpour, K M J Menon

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Pharmacogenomic of LH and its receptor: are we ready for clinical practice?Reproductive biology and endocrinology : RB&E · 2025
    Review
  3. Article
  4. Article
  5. The mRNA-destabilizing protein Tristetraprolin targets "meiosis arrester"Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Bindu MenonDepartment of Obstetrics/Gynecology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0617, USA. kmjmenon@umich.edu
Megan Franzo-Romain
Shadi Damanpour
K M J Menon
University of Michigan–Ann Arbor · US

Funding

Regulation Of Ovarian Function By GonadotropinR37HD006656 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MENON, JAIRAM K.M. · 2002 to 2011
$3.0M
NICHD NIH HHS R37 HD006656NICHD NIH HHS R37 HD06656
6 · The paper itself

Abstract

The ligand-induced down-regulation of LH receptor (LHR) expression in the ovaries, at least in part, is regulated by a posttranscriptional process mediated by a specific LH receptor mRNA binding protein (LRBP). The LH-mediated signaling pathways involved in this process were examined in primary cultures of human granulosa cells. Treatment with 10 IU human chorionic gonadotropin (hCG) for 12 h resulted in the down-regulation of LHR mRNA expression while producing an increase in LHR mRNA binding to LRBP as well as a 2-fold increase in LRBP levels. The activation of ERK1/2 pathway in LH-mediated LHR mRNA down-regulation was also established by demonstrating the translocation of ERK1/2 from the cytosol to the nucleus using confocal microcopy. Inhibition of protein kinase A using H-89 or ERK1/2 by U0126 abolished the LH-induced LHR mRNA down-regulation. These treatments also abrogated both the increases in LRBP levels as well as the LHR mRNA binding activity. The abolishment of the hCG-induced increase in LRBP levels and LHR mRNA binding activity was further confirmed by transfecting granulosa cells with ERK1/2 specific small interfering RNA. This treatment also reversed the hCG-induced down-regulation of LHR mRNA. These data show that LH-regulated ERK1/2 signaling is required for the LRBP-mediated down-regulation of LHR mRNA.

Indexed as

Down-RegulationBlotting, WesternButadienesCell LineCell NucleusChorionic GonadotropinCyclic AMP-Dependent Protein KinasesExtracellular Signal-Regulated MAP KinasesFemaleFluorescent Antibody TechniqueGranulosa CellsHumansIsoquinolinesMicroscopy, ConfocalNitrilesOvaryButadienesChorionic GonadotropinCyclic AMP-Dependent Protein KinasesExtracellular Signal-Regulated MAP KinasesIsoquinolinesmevalonate kinaseN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideNitrilesPhosphotransferases (Alcohol Group Acceptor)Receptors, LHRNA, MessengerRNA, Small InterferingSulfonamidesU 0126

Identifiers

PMID21147848
PMCPMC3386540
OpenAlexW1996837389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.